BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22238432)

  • 41. Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay.
    Wada K; Kubota N; Ito Y; Yagasaki H; Kato K; Yoshikawa T; Ono Y; Ando H; Fujimoto Y; Kiuchi T; Kojima S; Nishiyama Y; Kimura H
    J Clin Microbiol; 2007 May; 45(5):1426-32. PubMed ID: 17376882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.
    Cao P; Zhang M; Wang W; Dai Y; Sai B; Sun J; Wang L; Wang F; Li G; Xiang J
    BMC Infect Dis; 2017 May; 17(1):323. PubMed ID: 28468603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Commutability of the Epstein-Barr virus WHO international standard across two quantitative PCR methods.
    Abeynayake J; Johnson R; Libiran P; Sahoo MK; Cao H; Bowen R; Chan KC; Le QT; Pinsky BA
    J Clin Microbiol; 2014 Oct; 52(10):3802-4. PubMed ID: 25078918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting.
    Gulley ML; Fan H; Elmore SH
    J Mol Diagn; 2006 Nov; 8(5):589-97. PubMed ID: 17065428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen.
    Stevens SJ; Pronk I; Middeldorp JM
    J Clin Microbiol; 2001 Apr; 39(4):1211-6. PubMed ID: 11283029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epstein-Barr virus (EBV) load determination using real-time quantitative polymerase chain reaction.
    Fan H; Robetorye RS
    Methods Mol Biol; 2013; 999():231-43. PubMed ID: 23666703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
    Bauer CC; Aberle SW; Popow-Kraupp T; Kapitan M; Hofmann H; Puchhammer-Stöckl E
    J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients.
    Colombini E; Guzzo I; Morolli F; Longo G; Russo C; Lombardi A; Merli P; Barzon L; Murer L; Piga S; Ciofi Degli Atti ML; Locatelli F; Dello Strologo L
    Pediatr Nephrol; 2017 Aug; 32(8):1433-1442. PubMed ID: 28280938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.
    Gulley ML; Tang W
    Clin Microbiol Rev; 2010 Apr; 23(2):350-66. PubMed ID: 20375356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of four commercial EBV DNA quantitative tests to a new test at an early stage of development.
    Stelzl E; Kessler HH; Parulekar AD; Bier C; Nörz D; Schneider T; Kumar S; Simon CO; Lütgehetmann M
    J Clin Virol; 2023 Apr; 161():105400. PubMed ID: 36796282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analytical and clinical performance of a new molecular assay for Epstein-Barr virus DNA quantitation.
    Hübner M; Bozic M; Konrad PM; Grohs K; Santner BI; Kessler HH
    J Virol Methods; 2015 Feb; 212():39-43. PubMed ID: 25445796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
    Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
    Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Automated extraction of viral-pathogen RNA and DNA for high-throughput quantitative real-time PCR.
    Beuselinck K; van Ranst M; van Eldere J
    J Clin Microbiol; 2005 Nov; 43(11):5541-6. PubMed ID: 16272483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR.
    Dehee A; Asselot C; Piolot T; Jacomet C; Rozenbaum W; Vidaud M; Garbarg-Chenon A; Nicolas JC
    J Med Virol; 2001 Nov; 65(3):543-52. PubMed ID: 11596092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the sample-to-result, random access NeuMoDx platform for viral load testing of Cytomegalovirus and Epstein Barr virus in clinical specimens.
    Mourik K; Boers SA; van Rijn AL; Thijssen JCP; Doorn R; Svraka S; Bart A; Wessels E; Claas ECJ; Nijhuis RHT
    J Clin Virol; 2022 Apr; 149():105122. PubMed ID: 35299100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
    Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of a LightCycler-based real-time PCR for quantitation of Epstein-Barr viral load in different clinical specimens with semiquantitative PCR.
    Krumbholz A; Meerbach A; Zell R; Gruhn B; Henke A; Birch-Hirschfeld E; Wutzler P
    J Med Virol; 2006 May; 78(5):598-607. PubMed ID: 16555269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction.
    Wagner HJ; Wessel M; Jabs W; Smets F; Fischer L; Offner G; Bucsky P
    Transplantation; 2001 Sep; 72(6):1012-9. PubMed ID: 11579293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epstein-Barr virus (EBV) load in cerebrospinal fluid and peripheral blood of patients with EBV-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation.
    Liu QF; Ling YW; Fan ZP; Jiang QL; Sun J; Wu XL; Zhao J; Wei Q; Zhang Y; Yu GP; Wu MQ; Feng R
    Transpl Infect Dis; 2013 Aug; 15(4):379-92. PubMed ID: 23692640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.